High TEAD4 Expression is Associated With Aggressive Clear Cell Renal Cell Carcinoma, Regardless of YAP1 Expression
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High TEAD4 Expression is Associated With Aggressive Clear Cell Renal Cell Carcinoma, Regardless of YAP1 Expression
Authors
Keywords
-
Journal
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
Volume -, Issue -, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2023-10-02
DOI
10.1097/pai.0000000000001164
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TEAD4 is a master regulator of high-risk nasopharyngeal carcinoma
- (2023) Ya-Qin Wang et al. Science Advances
- The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
- (2022) Richard Cunningham et al. CLINICAL SCIENCE
- TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer
- (2022) Ming Chi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Pan-cancer analysis, cell and animal experiments revealing TEAD4 as a tumor promoter in ccRCC
- (2022) Fang Li et al. LIFE SCIENCES
- The biology of YAP in programmed cell death
- (2022) Yifan Cheng et al. Biomarker Research
- The Hippo pathway effector YAP inhibits HIF2 signaling and ccRCC tumor growth
- (2022) Xu Li et al. Cell Discovery
- Hippo/TEAD4 signaling pathway as a potential target for the treatment of breast cancer (Review)
- (2021) Yujian Wu et al. Oncology Letters
- Role of the Hippo pathway and mechanisms for controlling cellular localization of YAP/TAZ
- (2021) Hyeryun Kwon et al. FEBS Journal
- High YAP and TEAD4 immunolabelings are associated with poor prognosis in patients with gallbladder cancer
- (2021) Joo Young Kim et al. APMIS
- TEAD4 promotes tumor development in patients with lung adenocarcinoma via ERK signaling pathway
- (2020) Chang Gu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Systemic therapy for metastatic renal cell carcinoma in the first-line setting: a systematic review and network meta-analysis
- (2020) Keiichiro Mori et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Comparison of tumor-associated YAP1 fusions identifies a recurrent set of functions critical for oncogenesis
- (2020) Frank Szulzewsky et al. GENES & DEVELOPMENT
- VGLL4 with low YAP expression is associated with favorable prognosis in colorectal cancer
- (2020) Joo Young Kim et al. APMIS
- High Yes-associated protein 1 with concomitant negative LATS1/2 expression is associated with poor prognosis of advanced gastric cancer
- (2019) Eojin Kim et al. PATHOLOGY
- PI3K/AKT/β-Catenin Signaling Regulates Vestigial-Like 1 Which Predicts Poor Prognosis and Enhances Malignant Phenotype in Gastric Cancer
- (2019) Bo-Kyung Kim et al. Cancers
- TEAD4 promotes colorectal tumorigenesis via transcriptionally targeting YAP1
- (2018) Jia-Yin Tang et al. CELL CYCLE
- Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies
- (2018) Peter Makhov et al. MOLECULAR CANCER THERAPEUTICS
- TEAD4 overexpression promotes epithelial-mesenchymal transition and associates with aggressiveness and adverse prognosis in head neck squamous cell carcinoma
- (2018) Wei Zhang et al. Cancer Cell International
- The Ambivalent Function of YAP in Apoptosis and Cancer
- (2018) Xianbin Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Renal Cell Tumors: Understanding Their Molecular Pathological Epidemiology and the 2016 WHO Classification
- (2017) Kentaro Inamura INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome
- (2017) Agnieszka Rybarczyk et al. ONCOLOGY REPORTS
- Increased expression of YAP1 in prostate cancer correlates with extraprostatic extension
- (2017) Kisaayak Collak Filiz et al. Cancer Biology & Medicine
- TAZ and YAP are frequently activated oncoproteins in sarcomas
- (2016) Colleen A. Fullenkamp et al. Oncotarget
- Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironment
- (2016) Simonetta Buglioni et al. OncoImmunology
- Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
- (2015) Fa-Xing Yu et al. CELL
- A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis
- (2015) Toshiro Moroishi et al. GENES & DEVELOPMENT
- Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial–mesenchymal transition and metastasis in a YAP-independent manner
- (2015) Y Liu et al. ONCOGENE
- Prognostic Value of Yes-Associated Protein 1 (YAP1) in Various Cancers: A Meta-Analysis
- (2015) Zhenqiang Sun et al. PLoS One
- Effects of the Hippo Signaling Pathway in Human Gastric Cancer
- (2014) Guang-Xi Zhou et al. Asian Pacific Journal of Cancer Prevention
- Hippo-YAP signaling pathway: A new paradigm for cancer therapy
- (2014) Yanlei Ma et al. INTERNATIONAL JOURNAL OF CANCER
- YAP is overexpressed in clear cell renal cell carcinoma and its knockdown reduces cell proliferation and induces cell cycle arrest and apoptosis
- (2014) JIAN-JIA CAO et al. ONCOLOGY REPORTS
- The Biology of YAP/TAZ: Hippo Signaling and Beyond
- (2014) Stefano Piccolo et al. PHYSIOLOGICAL REVIEWS
- Role of YAP/TAZ in mechanotransduction
- (2011) Sirio Dupont et al. NATURE
- Structural basis of YAP recognition by TEAD4 in the Hippo pathway
- (2010) L. Chen et al. GENES & DEVELOPMENT
- TEAD mediates YAP-dependent gene induction and growth control
- (2008) B. Zhao et al. GENES & DEVELOPMENT
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More